IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for...

IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol – Technology Today

42
0
SHARE


IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol – Technology Today – EIN Presswire

Trusted News Since 1995

A service for technology industry professionals
·
Wednesday, October 21, 2020

·
528,892,576
Articles


·
3+ Million Readers

News Monitoring and Press Release Distribution Tools

Press Releases

Events & Conferences






Source link

LEAVE A REPLY